Abstract
Hemophagocytic lymphohistiocytosis (HLH) is a rare syndrome of pathologic immune activation in children that is increasingly being recognized in adults. Efficacy data for the HLH-04 protocol in adults is lacking. This study retrospectively analyzed 31 adult patients, median age 46 years, who received HLH-04 from 1/1/2004 to 5/1/2018. HLH etiology included malignancy (n = 9), autoimmune (n = 8), infection (n = 8), and idiopathic (n = 6). Eighteen patients were evaluable for response at week 4 with 7 having no response, 11 reaching partial response, and 0 reaching complete response (CR). Six patients eventually achieved CR at a median 195 days. The 1-year overall survival (OS) was 35% and median OS was 3.2 months. Univariate analysis showed shorter survival for hemoglobin <9 g/dL (HR 4.29, p = 0.003), platelets <100 × 109/L (HR 4.06, p = 0.027), ANC <1 × 109/L (HR 5.24, p = 0.001), and total bilirubin >1.2 mg/dL (HR 3.30, p = 0.022). Outcomes of adults treated with HLH-04 remain dismal and newer treatment modalities are needed.
References
Apr 1, 1991·Acta paediatrica Scandinavica·J I HenterA Ost
Jun 1, 1983·European Journal of Pediatrics·G E Janka
May 1, 1997·Medical and Pediatric Oncology·J I HenterD Webb
Apr 30, 1998·Hematology/oncology Clinics of North America·G JankaJ I Henter
Aug 29, 2006·Pediatric Blood & Cancer·Jan-Inge HenterGritta Janka
Oct 5, 2007·The Oncologist·Diana SuperfinAngela M Davies
Dec 17, 2009·Hematology·Alexandra H Filipovich
Sep 9, 2011·Blood·Helena TrottestamUNKNOWN Histiocyte Society
May 22, 2013·American Journal of Clinical Pathology·Flavia G N Rosado, Annette S Kim
Dec 3, 2013·Lancet·Manuel Ramos-CasalsXavier Bosch
Dec 10, 2013·Hematology·Gritta E Janka, Kai Lehmberg
Mar 4, 2014·Mayo Clinic Proceedings·Sameer A ParikhAlexandra P Wolanskyj
May 20, 2014·The American Journal of Medicine·Sébastien RivièreLaurence Fardet
Jun 27, 2014·Journal of Blood Medicine·Melissa R George
Mar 12, 2015·Orphanet Journal of Rare Diseases·Fei LiYe Yang
Mar 12, 2015·Blood·Alison M Schram, Nancy Berliner
Oct 16, 2015·Hematology/oncology Clinics of North America·Alexandra H Filipovich, Shanmuganathan Chandrakasan
Dec 8, 2015·Hematology·Carl E Allen, Kenneth L McClain
May 31, 2016·Blood Reviews·Anna HaydenLuke Y C Chen
Jun 14, 2016·British Journal of Haematology·Ellen BrisseCarine H Wouters
Mar 8, 2017·Scientia pharmaceutica·Tomi HendrayanaUlrich Jaehde
Jun 18, 2017·Cancer·Naval DaverHagop M Kantarjian
Sep 25, 2017·Blood·Elisabet BergstenJan-Inge Henter
Sep 12, 2018·The Journal of Allergy and Clinical Immunology. in Practice·Stephan EhlJan-Inge Henter
Sep 19, 2018·Mayo Clinic Proceedings. Innovations, Quality & Outcomes·Pilar Brito-ZerónUNKNOWN REGHEM-GEAS-SEMI Study Group
Apr 18, 2019·Blood·Paul La RoséeJan-Inge Henter
Citations
Oct 8, 2020·Journal of Cancer Research and Clinical Oncology·Liqiang WeiJingwen Wang
Apr 22, 2021·American Journal of Clinical Oncology·Wei YangXiaofeng Xu
Aug 5, 2021·Orphanet Journal of Rare Diseases·Shuyan YaoZhao Wang
Oct 26, 2021·Frontiers in Medicine·Amandine BichonJulien Carvelli